Alan has over 30 years private equity investment experience, with a strong track record of dedicated healthcare investing.
He is currently a member of the board at Ardena, Alcami, RoslinCT, X-Chem, and Sterling and previously Quotient Sciences until its successful exit.
Previously, Alan was a board member at 3i plc, led the build-out of the 3i Europe office network, and founded 3i’s healthcare sector team as Global Head of Healthcare. Subsequently, Alan was founder, CEO and Chairman of the Investment Committee at Hermes GPE, an active co-investor in private equity-backed healthcare.
Alan holds a Bachelor’s degree in Law, an MSc in Enterprise and is a graduate of the Advanced Management Programme at INSEAD. He was Chair of the BVCA and for a number of years chaired the BVCA Responsible Investment Advisory Board, and is currently Chairman of the European Healthcare Investors Association (EHIA).
